Saturday, April 17, 2021
Corporate Compliance Insights
  • Home
  • About
    • About CCI
    • Writing for CCI
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Topics
    • See All Articles
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Leadership and Career
  • Vendor News
  • Jobs
    • Compliance & Risk
    • Information Security
  • Events
    • Calendar
    • On-Demand Webinars
    • Submit an Event
  • Downloads
    • eBooks
    • Whitepapers
  • Podcasts
  • Videos
  • Subscribe
No Result
View All Result
  • Home
  • About
    • About CCI
    • Writing for CCI
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Topics
    • See All Articles
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Leadership and Career
  • Vendor News
  • Jobs
    • Compliance & Risk
    • Information Security
  • Events
    • Calendar
    • On-Demand Webinars
    • Submit an Event
  • Downloads
    • eBooks
    • Whitepapers
  • Podcasts
  • Videos
  • Subscribe
No Result
View All Result
Corporate Compliance Insights
Home Compliance

Limiting Adverse Consequences

Monitoring in the Health Care Sector, Part 5

by Jay Rosen
September 11, 2019
in Compliance, Featured
illustration of hand stopping falling dominos

Jay Rosen concludes his series on monitoring in health care with a consideration of how using an independent integrity assessment and monitoring can minimize negative impacts.

Many compliance practitioners in the health care space (and those in commercial space) often ask if an independent integrity review and monitoring would be helpful where an organization may have reason to believe it has an actual or potential compliance problem but has not yet been subject to an enforcement action or a corporate integrity agreement (CIA) imposed by the government.

There are several reasons this is particularly true in the health care space. Government expects – in fact, demands – that health care organizations self-report certain types of compliance violations. Some examples include over-payments providers may have received from the government, false or fraudulent claims they have billed the government and certain types of privacy breaches.

Using an independent compliance expert can be useful in dealing with a government enforcement agency and convincing that agency to look more favorably where severe sanctions might otherwise be imposed.

An independent integrity monitor can be helpful to a health care organization where they may have compliance violations. It can even be true with current health care issues, such as the opioid crisis and excessive opioid prescribing.

This is where an independent integrity monitor can be useful when a organization thinks they have a problem: A monitor can be brought in to assess the compliance program, make recommendations for improvements and then be available to monitor the remedial recommendations as they are implemented. If an organization makes a self-disclosure or if the government comes and investigates the company, they can use the fact that they have engaged an independent integrity monitor to assess the compliance program – and, equally importantly, themselves – and they will continue to use the monitor to ensure continued compliance.

By using an independent integrity assessment, an organization can demonstrate to the government entity that the problems with the company’s compliance regime are not endemic or structural, but more isolated.

This can help to provide both confidence to the public that the entity can continue to operate safely in compliance and assurance to the government and regulators that it can continue to participate in the government programs with little fear of having those violations reoccur. This can impact what types of action the government or regulator will take.

The bottom line in health care regulation is that government regulatory and enforcement agencies would prefer not to exclude important health care providers who have compliance issues.

Their goal to ensure access to enough quality providers is a constant challenge for health care policymakers. Regulators generally agree that the best solution is to have providers with compliance issues remediate their problems and implement a sustainable and effective ethical compliance program. Engaging an independent compliance expert and monitor can provide the government with confidence that organization has remediated and will be an effective, compliant participant.

To use a couple of live examples, let’s look at how an independent integrity monitor could have intervened in the fraud at Theranos, Inc. and the opioid crisis. With regard to Theranos, a wide variety of stakeholders could have requested a truly independent monitor come in and assess compliance at the company. It could have been the board of directors, the Securities and Exchange Commission (SEC), state or federal health care regulators or even third parties who were looking to do joint ventures with the company. Such an assessment might have saved many jobs, investments, careers and reputations.

In the opioid crisis, an independent monitor could have done the assessment around large numbers of drugs being prescribed by one doctor or prescribed to be delivered through one pharmacy.

But the analysis could have gone much deeper by focusing on the corporate compliance programs, their implementation and their training. It could have also looked at those who spoke up by using the hotline or other internal reporting mechanisms. All of this means that an independent integrity monitor in the health care space can be used in a variety of ways and through a variety of mechanisms.

Please join me next week when I begin a new five-part series on what ethical culture is and why it matters.


In case you missed the earlier installments of this ongoing series, please see the links below.

Everything You Always Wanted to Know About Monitors But Were Afraid to Ask

Part 1, Part 2, Part 3, Part 4 and Part 5

Potential Issues in Corporate Monitorships

Part 1, Part 2, Part 3, Part 4 and Part 5

Suspension and Debarment in Monitoring

Part 1, Part 2, Part 3, Part 4 and Part 5

Monitoring in the Health Care Sector

Part 1, Part 2, Part 3, Part 4


Tags: health caremonitoring
Previous Post

Consequences of Low-Level Ethics at Google and Wayfair

Next Post

CCPA: An 800-Pound Gorilla Setting the National Data Privacy Standard

Jay Rosen

Jay Rosen is Vice President, Business Development and Monitoring Specialist at Affiliated Monitors, Inc., the first company in the U.S. to focus on providing independent integrity monitoring and assessment services across a wide range of regulated industries and professions. Jay previously headed up Merrill Brink’s FCPA Investigations and Ethics and Compliance translation group. He has over eight years of experience assisting clients on cross-border investigations, as well as helping them localize their code of conduct and other mission-critical English documents for their global colleagues. For almost three years, Jay has co-hosted the #1 weekly FCPA podcast, “This Week in FCPA,” with Tom Fox. Tom and Jay recently launched a second podcast, “Popcorn and Compliance,” and Jay is also a commentator on the biweekly podcast, “Everything Compliance,” with Jonathan Armstrong, Tom Fox, Sarah Hadden, Matt Kelly and Mike Volkov.

Related Posts

Business professionals stand in silhouette in a conference room.

How Far Will You Go?

April 16, 2021
allustration of a man looking at a moon through a telescope

Periodic Reporting for Public Companies in 2021: What Lies Ahead

April 14, 2021
A view of the Veriff mobile app

Estonian Identity Verification Service Veriff Raises $69M in Series B Led by IVP and Accel

April 13, 2021
President Joe Biden.

The Biden Administration Is Ramping Up Numerous Cross-Border Enforcements. Compliance Teams Should Take Note.

April 13, 2021
Next Post
closeup of gorilla on black background

CCPA: An 800-Pound Gorilla Setting the National Data Privacy Standard

2Behavox and CCI webinar: Power of Ai in F
OneTrust offers download to demonstrate privacy management leadership
Top 10 Risk and Compliance Trends

Jump to a Topic:

anti-corruption anti-money laundering/AML Artificial Intelligence/A.I. automation banks board of directors board risk oversight bribery CCPA/California Consumer Privacy Act Cloud Compliance communications management Coronavirus/COVID-19 corporate culture crisis management culture of ethics cyber crime cyber risk data analytics data breach data governance decision-making diversity DOJ due diligence ESG fcpa enforcement actions financial crime GDPR GRC HIPAA information security KYC machine learning monitoring regtech reputation risk risk assessment Sanctions SEC social media risk technology third party risk management tone at the top training whistleblowing
No Result
View All Result

Privacy Policy

Follow Us

  • Facebook
  • Twitter
  • LinkedIn
  • RSS Feed

Category

  • CCI Press
  • Compliance
  • Compliance Podcasts
  • Cybersecurity
  • Data Privacy
  • eBooks
  • Ethics
  • FCPA
  • Featured
  • Financial Services
  • Fraud
  • Governance
  • GRC Vendor News
  • HR Compliance
  • Internal Audit
  • Leadership and Career
  • On Demand Webinars
  • Opinion
  • Resource Library
  • Risk
  • Uncategorized
  • Videos
  • Webinars
  • Whitepapers

© 2021 Corporate Compliance Insights

No Result
View All Result
  • Home
  • About
    • About CCI
    • Writing for CCI
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Topics
    • See All Articles
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Leadership and Career
  • Vendor News
  • Jobs
    • Compliance & Risk
    • Information Security
  • Events
    • Calendar
    • On-Demand Webinars
    • Submit an Event
  • Downloads
    • eBooks
    • Whitepapers
  • Podcasts
  • Videos
  • Subscribe

© 2021 Corporate Compliance Insights